Short-Course versus Standard-Course Antibiotic Therapy for Pneumonia in Adult: A Systematic Review
Abstract
Pneumonia remains a significant cause of morbidity and mortality among adults worldwide, with substantial impacts on healthcare utilization and costs. Despite advancements in vaccines, diagnostics, and antimicrobial therapy, optimizing antibiotic duration remains a clinical challenge. Traditional regimens typically span 7–14 days, but prolonged therapy contributes to antimicrobial resistance, adverse events, and higher healthcare expenses. This study aims to evaluate the effectiveness and safety of short-course (?7 days) versus standard-course (?7 days) antibiotic therapy in adult patients with pneumonia. A systematic review was conducted following PRISMA guidelines, including randomized controlled trials and observational studies published between 2016 and 2026. Data on clinical cure, mortality, recurrence, hospital length of stay, and adverse events were extracted and analyzed. Results from seven studies involving 5,467 patients indicate that short-course therapy is generally non-inferior to standard-course therapy in terms of clinical cure and mortality, particularly among patients achieving early clinical stability. Recurrence rates were comparable, while some studies demonstrated reduced hospital stay and fewer antibiotic-related adverse events in short-course groups. These findings support individualized treatment durations guided by clinical response rather than fixed periods. In conclusion, short-course antibiotic therapy is an effective and safe strategy for…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 5,467 participants or records.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.